신경과용 디지털 헬스 시장 규모, 점유율, 동향 분석 리포트 : 컴포넌트별, 최종 용도별, 지역별 전망과 예측(2023-2030년)
Global Digital Health In Neurology Market Size, Share & Trends Analysis Report By Component (Services, Software and Hardware), By End Use (Patients, Providers, Payers and Others), By Regional Outlook and Forecast, 2023 - 2030
상품코드:1457211
리서치사:KBV Research
발행일:2024년 03월
페이지 정보:영문 174 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 신경과용 디지털 헬스 시장 규모는 2030년까지 1,308억 달러에 달할 것으로 예상되고 있으며, 예측 기간 중 22.2%의 CAGR로 시장 성장이 전망됩니다.
또한 알츠하이머병, 파킨슨병, 간질, 다발성 경화증과 같은 신경 질환의 유병률 증가로 인해 첨단 혁신적 디지털 헬스 솔루션에 대한 수요가 증가하고 있습니다. 범미보건기구(PAHO) 자료에 따르면 2019년 범미보건기구(PAHO) 지역에서 신경질환으로 인한 사망자 수는 53만 3,172명이며, 이 중 여성은 32만 43명(60%), 남성은 21만 3,129명(40%)으로 나타났습니다. 디지털 헬스 솔루션은 첨단 진단 툴와 기술을 통합하여 신경 질환의 조기 발견과 진단에 기여합니다.
그러나 신경과용 디지털 헬스 용도의 규제 환경은 다양한 규제와 표준을 준수해야 하는 등 다면적인 측면이 있습니다. 보험사 및 지불자로부터 상환 승인을 받는 것은 규제 준수와 밀접한 관련이 있습니다. 신경학 용도의 임상적 및 경제적 가치를 입증하는 것은 상환을 받기 위해 필수적이지만 시간이 오래 걸릴 수 있습니다. 따라서 이러한 요인들이 시장 수요를 방해할 수 있습니다. 의료의 도입이 가속화되면서 환자가 원격으로 진찰과 후속 치료를 받을 수 있게 되었습니다. 원격의료 플랫폼은 의료 현장에서 바이러스 감염의 위험을 최소화하면서 진료의 연속성을 유지하는 데 필수적인 요소가 되었습니다. 원격 모니터링 장비와 웨어러블 기술을 포함한 디지털 건강 솔루션은 만성 신경 질환 환자를 모니터링하기 위해 주목받고 있습니다. 원격 모니터링은 의료 전문가에게 환자의 활력 징후, 증상, 복약 순응도에 대한 실시간 데이터를 제공하여 예방적 개입을 가능하게 합니다. 이처럼 COVID-19 팬데믹은 시장에 긍정적인 영향을 미쳤습니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 요약
주요 하이라이트
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 촉진요인
시장 억제요인
시장 기회
시장이 해결해야 할 과제
Porter's Five Forces 분석
제4장 신경과용 디지털 헬스 시장에서 도입되는 전략
제5장 세계 시장 : 컴포넌트별
세계의 서비스 시장 : 지역별
세계의 소프트웨어 시장 : 지역별
세계의 하드웨어 시장 : 지역별
제6장 세계 시장 : 최종 용도별
세계의 환자 시장 : 지역별
세계의 프로바이더 시장 : 지역별
세계의 지불자 시장 : 지역별
세계의 기타 시장 : 지역별
제7장 세계 시장 : 지역별
북미
북미의 시장 : 국가별
미국
캐나다
멕시코
기타 북미 지역
유럽
유럽의 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽 지역
아시아태평양
아시아태평양의 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카·중동 및 아프리카
라틴아메리카·중동 및 아프리카의 시장 : 국가별
브라질
아르헨티나
아랍에미리트
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카·중동 및 아프리카
제8장 기업 개요
Neofect
Teladoc Health, Inc
Omada Health, Inc
AdvancedMD, Inc(Global Payments Inc.)
Blackrock Microsystems, Inc
Big Health Inc
BehaVR, Inc
Aural Analytics, Inc
AppliedVR, Inc
Akili, Inc
제9장 신경과용 디지털 헬스 시장의 성공 필수 조건
KSA
영문 목차
영문목차
The Global Digital Health In Neurology Market size is expected to reach $130.8 billion by 2030, rising at a market growth of 22.2% CAGR during the forecast period.
The North American healthcare system has been increasingly adopting telehealth solutions, which will likely impact neurology as well. Consequently, the North America segment captured $10,366.7 million revenue in the market in 2022. Telehealth platforms allow patients to consult with neurologists remotely, improving access to care, especially for individuals in remote or underserved areas. Hence, these segments will expand rapidly in the coming years.
Wearable devices can continuously track vital signs such as heart rate, respiratory rate, and blood pressure. For individuals with neurological disorders, changes in vital signs can provide early indications of potential issues or the effectiveness of ongoing treatments. Moreover, wearable devices with sleep monitoring capabilities offer insights into sleep patterns and disturbances. Sleep disturbances are common in neurological disorders such as epilepsy and can be important indicators for diagnosis and treatment adjustments. Some advanced wearable devices have EEG sensors that can monitor brainwave activity.
Additionally, the increasing prevalence of neurological disorders, encompassing conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, has led to a growing demand for advanced and innovative digital health solutions. As per the data from the Pan American Health Organization (PAHO), neurological disorders caused 533,172 deaths in the Pan American Health Organization (PAHO) region in 2019, of which 320,043 (60%) were women and 213,129 (40%) were males. Digital health solutions contribute to the early detection and diagnosis of neurological disorders by integrating advanced diagnostic tools and technologies.
However, the regulatory environment for digital health applications in neurology is multifaceted, involving adherence to various regulations and standards. Obtaining reimbursement approval from insurance providers and payers is closely tied to regulatory compliance. Demonstrating the clinical and economic value of neurology applications is essential for gaining reimbursement, but this can be lengthy. Hence, these factors can hamper the demand in the market.
Moreover, the pandemic accelerated the adoption of telehealth in neurology, allowing patients to receive consultations and follow-up care remotely. Telehealth platforms became essential for maintaining continuity of care while minimizing the risk of virus transmission in healthcare settings. Digital health solutions, including remote monitoring devices and wearable technologies, gained prominence for monitoring patients with chronic neurological conditions. Remote monitoring provided healthcare professionals real-time data on patients' vital signs, symptoms, and medication adherence, enabling proactive intervention. Thus, the COVID-19 pandemic positively impacted the market.
By Component Analysis
Based on component, the market is segmented into software, hardware, and services. The software segment held a 36.25% revenue share in the market in 2022. Advanced diagnostic tools and software, such as MRI and CT scans, aid in analyzing neuroimaging data. Machine learning algorithms and artificial intelligence (AI) are increasingly being utilized to assist in the early detection and diagnosis of neurological disorders.
By End Use Analysis
On the basis of end use, the market is divided into patients, providers, payers, and others. The patients segment recorded the 36.39% revenue share in the market in 2022. Patients with neurological conditions often face challenges in traveling to healthcare facilities. Digital health enables remote monitoring and telemedicine consultations, providing convenience for patients and healthcare providers. Continuous monitoring of neurological conditions through wearable devices and at-home sensors helps track symptoms, provide timely interventions, and improve overall management.
By Regional Analysis
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a 38.5% revenue share in the market. Several European countries have implemented initiatives to promote digital health and enhance healthcare infrastructure. These may include funding for research and development, regulatory frameworks for digital health solutions, and technology integration into existing healthcare systems.
Market Competition and Attributes
Competition in the digital health sector within neurology is burgeoning as technological advancements continue to transform healthcare delivery. Established players and startups alike are fiercely competing to provide innovative solutions for neurological conditions, ranging from remote patient monitoring and telemedicine platforms to wearable devices and AI-driven diagnostics. Key factors driving competition include the increasing prevalence of neurological disorders, demand for personalized healthcare solutions, regulatory approvals, data security, and interoperability standards. Companies strive to differentiate themselves through superior technology, user experience, clinical efficacy, and partnerships with healthcare providers and research institutions, while navigating challenges such as data privacy concerns and reimbursement models.
Recent Strategies Deployed in the Market
Feb-2024: Akili, Inc.'s digital therapeutic EndeavorRx has received approval from the U.S. FDA to treat pediatric patients with attention deficit hyperactivity disorder (ADHD). This approval will improve attentional functioning in pediatric patients (aged 8-17 years) with ADHD.
Nov-2023: BehaVR, LLC. merged with Fern Health to introduce RealizedCare, a pioneering digital care management solution focused on chronic pain. The strategic partnership aimed to meet the rising demand for evidence-based, scalable, and economically viable solutions in mental and behavioral health.
Jul-2023: Big Health Inc. has acquired Limbix, the creators of the first evidence-based digital therapeutic for teens, to help millions return to good mental health. This acquisition will enable a record number of adult and adolescent patients to get immediate access to safe and effective non-drug options.
Mar-2023: Aural Analytics, Inc. received U.S. FDA approval for its Speech Vitals-ALS technology, a software application that collects and analyzes speech recordings to help monitor amyotrophic lateral sclerosis (ALS) in adults in clinic and home settings. This software can improve the management of this devastating disease.
List of Key Companies Profiled
Neofect
Teladoc Health, Inc.
Omada Health, Inc.
AdvancedMD, Inc.
Blackrock Microsystems Inc.
Big Health Inc.
BehaVR, LLC.
Aural Analytics, Inc.
AppliedVR, Inc.
Akili, Inc.
Global Digital Health In Neurology Market Report Segmentation
By Component
Services
Software
Hardware
By End Use
Patients
Providers
Payers
Others
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
1.4.1Global Digital Health In Neurology Market, by Component
1.4.2Global Digital Health In Neurology Market, by End Use
1.4.3Global Digital Health In Neurology Market, by Geography
1.5Methodology for the research
Chapter 2.Market at a Glance
2.1Key Highlights
Chapter 3.Market Overview
3.1Introduction
3.1.1Overview
3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
3.2.1Market Drivers
3.2.2Market Restraints
3.2.3Market Opportunities
3.2.4Market Challenges
3.3Porter's Five Forces Analysis
Chapter 4.Strategies Deployed in Digital Health In Neurology Market
Chapter 5.Global Digital Health In Neurology Market by Component
5.1Global Services Market by Region
5.2Global Software Market by Region
5.3Global Hardware Market by Region
Chapter 6.Global Digital Health In Neurology Market by End Use
6.1Global Patients Market by Region
6.2Global Providers Market by Region
6.3Global Payers Market by Region
6.4Global Others Market by Region
Chapter 7.Global Digital Health In Neurology Market by Region
7.1North America Digital Health In Neurology Market
7.1.1North America Digital Health In Neurology Market by Component
7.1.1.1North America Services Market by Country
7.1.1.2North America Software Market by Country
7.1.1.3North America Hardware Market by Country
7.1.2North America Digital Health In Neurology Market by End Use
7.1.2.1North America Patients Market by Country
7.1.2.2North America Providers Market by Country
7.1.2.3North America Payers Market by Country
7.1.2.4North America Others Market by Country
7.1.3North America Digital Health In Neurology Market by Country
7.1.3.1US Digital Health In Neurology Market
7.1.3.1.1US Digital Health In Neurology Market by Component
7.1.3.1.2US Digital Health In Neurology Market by End Use
7.1.3.2Canada Digital Health In Neurology Market
7.1.3.2.1Canada Digital Health In Neurology Market by Component
7.1.3.2.2Canada Digital Health In Neurology Market by End Use
7.1.3.3Mexico Digital Health In Neurology Market
7.1.3.3.1Mexico Digital Health In Neurology Market by Component
7.1.3.3.2Mexico Digital Health In Neurology Market by End Use
7.1.3.4Rest of North America Digital Health In Neurology Market
7.1.3.4.1Rest of North America Digital Health In Neurology Market by Component
7.1.3.4.2Rest of North America Digital Health In Neurology Market by End Use
7.2Europe Digital Health In Neurology Market
7.2.1Europe Digital Health In Neurology Market by Component
7.2.1.1Europe Services Market by Country
7.2.1.2Europe Software Market by Country
7.2.1.3Europe Hardware Market by Country
7.2.2Europe Digital Health In Neurology Market by End Use
7.2.2.1Europe Patients Market by Country
7.2.2.2Europe Providers Market by Country
7.2.2.3Europe Payers Market by Country
7.2.2.4Europe Others Market by Country
7.2.3Europe Digital Health In Neurology Market by Country
7.2.3.1Germany Digital Health In Neurology Market
7.2.3.1.1Germany Digital Health In Neurology Market by Component
7.2.3.1.2Germany Digital Health In Neurology Market by End Use
7.2.3.2UK Digital Health In Neurology Market
7.2.3.2.1UK Digital Health In Neurology Market by Component
7.2.3.2.2UK Digital Health In Neurology Market by End Use
7.2.3.3France Digital Health In Neurology Market
7.2.3.3.1France Digital Health In Neurology Market by Component
7.2.3.3.2France Digital Health In Neurology Market by End Use
7.2.3.4Russia Digital Health In Neurology Market
7.2.3.4.1Russia Digital Health In Neurology Market by Component
7.2.3.4.2Russia Digital Health In Neurology Market by End Use
7.2.3.5Spain Digital Health In Neurology Market
7.2.3.5.1Spain Digital Health In Neurology Market by Component
7.2.3.5.2Spain Digital Health In Neurology Market by End Use
7.2.3.6Italy Digital Health In Neurology Market
7.2.3.6.1Italy Digital Health In Neurology Market by Component
7.2.3.6.2Italy Digital Health In Neurology Market by End Use
7.2.3.7Rest of Europe Digital Health In Neurology Market
7.2.3.7.1Rest of Europe Digital Health In Neurology Market by Component
7.2.3.7.2Rest of Europe Digital Health In Neurology Market by End Use
7.3Asia Pacific Digital Health In Neurology Market
7.3.1Asia Pacific Digital Health In Neurology Market by Component
7.3.1.1Asia Pacific Services Market by Country
7.3.1.2Asia Pacific Software Market by Country
7.3.1.3Asia Pacific Hardware Market by Country
7.3.2Asia Pacific Digital Health In Neurology Market by End Use
7.3.2.1Asia Pacific Patients Market by Country
7.3.2.2Asia Pacific Providers Market by Country
7.3.2.3Asia Pacific Payers Market by Country
7.3.2.4Asia Pacific Others Market by Country
7.3.3Asia Pacific Digital Health In Neurology Market by Country
7.3.3.1China Digital Health In Neurology Market
7.3.3.1.1China Digital Health In Neurology Market by Component
7.3.3.1.2China Digital Health In Neurology Market by End Use
7.3.3.2Japan Digital Health In Neurology Market
7.3.3.2.1Japan Digital Health In Neurology Market by Component
7.3.3.2.2Japan Digital Health In Neurology Market by End Use
7.3.3.3India Digital Health In Neurology Market
7.3.3.3.1India Digital Health In Neurology Market by Component
7.3.3.3.2India Digital Health In Neurology Market by End Use
7.3.3.4South Korea Digital Health In Neurology Market
7.3.3.4.1South Korea Digital Health In Neurology Market by Component
7.3.3.4.2South Korea Digital Health In Neurology Market by End Use
7.3.3.5Singapore Digital Health In Neurology Market
7.3.3.5.1Singapore Digital Health In Neurology Market by Component
7.3.3.5.2Singapore Digital Health In Neurology Market by End Use
7.3.3.6Malaysia Digital Health In Neurology Market
7.3.3.6.1Malaysia Digital Health In Neurology Market by Component
7.3.3.6.2Malaysia Digital Health In Neurology Market by End Use
7.3.3.7Rest of Asia Pacific Digital Health In Neurology Market
7.3.3.7.1Rest of Asia Pacific Digital Health In Neurology Market by Component
7.3.3.7.2Rest of Asia Pacific Digital Health In Neurology Market by End Use
7.4LAMEA Digital Health In Neurology Market
7.4.1LAMEA Digital Health In Neurology Market by Component
7.4.1.1LAMEA Services Market by Country
7.4.1.2LAMEA Software Market by Country
7.4.1.3LAMEA Hardware Market by Country
7.4.2LAMEA Digital Health In Neurology Market by End Use
7.4.2.1LAMEA Patients Market by Country
7.4.2.2LAMEA Providers Market by Country
7.4.2.3LAMEA Payers Market by Country
7.4.2.4LAMEA Others Market by Country
7.4.3LAMEA Digital Health In Neurology Market by Country
7.4.3.1Brazil Digital Health In Neurology Market
7.4.3.1.1Brazil Digital Health In Neurology Market by Component
7.4.3.1.2Brazil Digital Health In Neurology Market by End Use
7.4.3.2Argentina Digital Health In Neurology Market
7.4.3.2.1Argentina Digital Health In Neurology Market by Component
7.4.3.2.2Argentina Digital Health In Neurology Market by End Use
7.4.3.3UAE Digital Health In Neurology Market
7.4.3.3.1UAE Digital Health In Neurology Market by Component
7.4.3.3.2UAE Digital Health In Neurology Market by End Use
7.4.3.4Saudi Arabia Digital Health In Neurology Market
7.4.3.4.1Saudi Arabia Digital Health In Neurology Market by Component
7.4.3.4.2Saudi Arabia Digital Health In Neurology Market by End Use
7.4.3.5South Africa Digital Health In Neurology Market
7.4.3.5.1South Africa Digital Health In Neurology Market by Component
7.4.3.5.2South Africa Digital Health In Neurology Market by End Use
7.4.3.6Nigeria Digital Health In Neurology Market
7.4.3.6.1Nigeria Digital Health In Neurology Market by Component
7.4.3.6.2Nigeria Digital Health In Neurology Market by End Use
7.4.3.7Rest of LAMEA Digital Health In Neurology Market
7.4.3.7.1Rest of LAMEA Digital Health In Neurology Market by Component
7.4.3.7.2Rest of LAMEA Digital Health In Neurology Market by End Use
Chapter 8.Company Profiles
8.1Neofect
8.1.1Company Overview
8.1.2SWOT Analysis
8.2Teladoc Health, Inc.
8.2.1Company Overview
8.2.2Financial Analysis
8.2.3Regional Analysis
8.2.4Research & Development Expenses
8.2.5Recent strategies and developments:
8.2.5.1Product Launches and Product Expansions:
8.2.6SWOT Analysis
8.3Omada Health, Inc.
8.3.1Company Overview
8.3.2SWOT Analysis
8.4AdvancedMD, Inc. (Global Payments Inc.)
8.4.1Company Overview
8.4.2SWOT Analysis
8.5Blackrock Microsystems, Inc.
8.5.1Company Overview
8.5.2Recent strategies and developments:
8.5.2.1Acquisition and Mergers:
8.5.2.2Trials & Approvals:
8.5.3SWOT Analysis
8.6Big Health Inc.
8.6.1Company Overview
8.6.2Recent strategies and developments:
8.6.2.1Acquisition and Mergers:
8.6.3SWOT Analysis
8.7BehaVR, Inc.
8.7.1Company Overview
8.7.2Recent strategies and developments:
8.7.2.1Partnerships, Collaborations, and Agreements:
8.8Aural Analytics, Inc.
8.8.1Company Overview
8.8.2Recent strategies and developments:
8.8.2.1Partnerships, Collaborations, and Agreements:
8.8.2.2Trials & Approvals:
8.9AppliedVR, Inc.
8.9.1Company Overview
8.10.Akili, Inc.
8.10.1Company Overview
8.10.2Financial Analysis
8.10.3Research & Development Expenses
8.10.4Recent strategies and developments:
8.10.4.1Trials & Approvals:
8.10.5SWOT Analysis
Chapter 9.Winning Imperatives of Digital Health In Neurology Market